Husband & Papa | Interventional Cardiologist @StanfordHealth | CV and IC @UCLAHealth | CR @UCIMR | Clinical Researcher | CA Burrito Enthusiast | Tweets = Own

Joined July 2020
5 Photos and videos
Medical school, masters, residency, chief residency, CV fellowship, and interventional cardiology fellowship all done. Huge thanks to all my teachers and mentors, but biggest thanks to @KatharinaLaus for unwavering support. Looking forward to the next step @StanfordHealth
5
2
45
4,781
David Tehrani retweeted
"It wasn't mental health that killed these people, it was an automatic rifle with bullets... I'm a former police officer, a former Army officer. These M4s, AR-15s, they've got to get off the streets or this is going to keep happening" - Allen, TX mall shooting witness Steven Spainhouer tells @CapehartJ on @weekendcapehart
5,548
11,148
45,620
5,713,622
David Tehrani retweeted
Great talk by @datsunian on #ASCVD in immune checkpoint inhibitor tx pts. Important role of #YesCCT! #CardioOnc
7
16
1,271
Thanks to @AmericanHeartJ and my collaborators to help publish this work showing no increase in early angiographic CAV after the 2018 UNOS heart allocation policy change to prioritize the highest acuity patients. Special thx to @rushiparikh11 for his mentorship
Early trends in cardiac allograft vasculopathy after implementation of the 2018 donor heart allocation policy in the United States. pubmed.ncbi.nlm.nih.gov/3597… @DavidTehrani3 @JeffHsuMD @AliNsairMD @KiranKhush1 @wfearonmd @Rushiparikh1111 #Cardiology
1
3
18
3,852
David Tehrani retweeted
Happy to share work led by @DavidTehrani3 in @AmericanHeartJ w/ collaborators @JeffHsuMD @AliNsairMD @KiranKhush1 @wfearonmd showing that recent change in UNOS donor heart allocation policy prioritizing highest acuity pts did not lead to ⬆️early angiographic CAV. @uclaCVfellows
Early trends in cardiac allograft vasculopathy after implementation of the 2018 donor heart allocation policy in the United States. pubmed.ncbi.nlm.nih.gov/3597… @DavidTehrani3 @JeffHsuMD @AliNsairMD @KiranKhush1 @wfearonmd @Rushiparikh1111 #Cardiology
5
21
2,804
David Tehrani retweeted
Congrats Dr. Eric Yang (@datsunian) appointed to @ACCinTouch Prog. Directors/Med. Educators Leadership Council! As a cardio-oncology expert, he will work alongside other leaders to enhance training & treatment for cancer patients subject to cardiac comorbidities & complications.
14
15
121
25,147
David Tehrani retweeted
28 Dec 2022
Echo predictors of residual #MR s/p #TEER: ✅ Bicommissural MR ✅ Annular dilation ✅ Smaller MVA:LVEDV ratio 📰➡️ doi.org/10.1016/j.jscai.2022… @JLabin_MD @MCalfonPressMD @DavidTehrani3 @datsunian @rushiparikh11
6
9
2,201
David Tehrani retweeted
Proud to share this published work led by my super⭐️ research mentees @jukakim_med @rshanmd @negeen_sh @DavidTehrani3 at the @DOM_UCLA Research Day! #WIC @uclaCVfellows @gcfmd @datsunian @IntMedAbel
7
40
A common source of confusion in the cath lab: coronary physiology can be cofounded in those with concomiant AS, Afib, LVH, serial disease. Understanding FFR/NHPR limitations can explain discordance and guide clinical decision making. Check out our review! authors.elsevier.com/a/1f~…

2
David Tehrani retweeted
Wonderful discussion by @DavidTehrani3 on an interesting/challenging IC case at the Los Angeles City Wide Cath Conference organized by @MCalfonPressMD. Great collaboration between institutes in LA and learning from each other’s best practices. Looking forward to many more!
3
16
David Tehrani retweeted
3
10
36
Check out our review of managmenet of coronary complications. A timely review after having one my first a few weeks back. Knowing steps in treatment without hesistation really can be the difference between life an death for our patients. @UCLA_IC #ICFIT authors.elsevier.com/a/1fiqZ…

1
8
David Tehrani retweeted
Excited to see our #bruinhearts @uclaCVfellows chief #celsodiaz & @DOM_UCLA ⭐️ @JTVuongMD present this @CaliforniaACC #cardioonc kickoff of “❤️ on 🔥” presenting ICI related cases! Led by @BrentonBauerMD w/ @UCLAJCCC #deborahwong co-paneling, don’t miss it! @uclaimchiefs
Join us for California ACC Cardio-Oncology Web Rounds! Leading experts Dr. Jacqueline Vuong, Dr. Celso Diaz, Dr. Eric Yang, and Dr. Deborah Wong will be discussing Heart on Fire: ICI related myocarditis clinical presentations! caacc.org/calendar/ #cardiotwitter
5
26
David Tehrani retweeted
10-year BEST Trial results show no difference btw PCI w everolimus-eluting stent vs CABG in reducing all-cause death, MI, or TVR thru 10y in MVD. Spontaneous MI & repeat revasc higher in PCI group #TCT2022
6
82
188
David Tehrani retweeted
Looking forward to learning about the #latest #updates in #IC and #SHD disease at the @UCLA Annual #HeartFailure #Symposium today! @RaviDaveMD1 @olcayaksoymd @AliNsairMD @rushiparikh11 @gcfmd
4
12
RT @uclaCVfellows: Masterful case conference featuring prior @uclaimchiefs and current @uclaCVfellows @SamJacksonMD1. Fascinating left main…
5
David Tehrani retweeted
Excited to share work led by @DavidTehrani3 @uclaCVfellows showing that recent change in UNOS donor heart allocation policy prioritizing highest-acuity pts did not lead to more early angiographic CAV. Thanks to collaborators @JeffHsuMD @AliNsairMD @KiranKhush1 @wfearonmd.
In Press: Early Trends in Cardiac Allograft Vasculopathy After Implementation of the 2018 Donor Heart Allocation Policy in the United States sciencedirect.com/science/ar… #CardioTwitter #Cardiology @DavidTehrani3 @JeffHsuMD @AliNsairMD @KiranKhush1 @wfearonmd @rushiparikh11
5
18
David Tehrani retweeted
Elegant & simple way to approach wide QRS complex tachycardias! Get a history and just look at Leads II and aVR! See editorial by Prof. Pedro Brugada talking about Ockham & Bayes! @uclaCVfellows From @jaccjournals jacc.org/doi/10.1016/j.jacep…
6
147
400
David Tehrani retweeted
Today, the Supreme Court not only reversed nearly 50 years of precedent, it relegated the most intensely personal decision someone can make to the whims of politicians and ideologues—attacking the essential freedoms of millions of Americans.
33,770
163,417
725,848